If you’ve ever put off seeing the doctor, for whatever reason, we have some expert advice on today on why you should never delay your medical care. We stopped by ...

Humana reported lower third-quarter profit and slashed full-year earnings guidance as medical costs continue to surge, dragging down margins for the company’s core Medicare Advantage business.

The agreement, which goes into effect Jan. 1, closes tense negotiations between the healthcare giant and the insurer for ...

Ariel Investments, an investment management company, released its “Ariel Global Fund” third-quarter 2025 investor letter. A ...

Health insurer Humana reported third-quarter profit that beat Wall Street estimates on Wednesday, helped by higher premiums ...

Health insurer Humana's shares fell more than 7% after it did not provide performance commentary for 2026, disappointing ...

Humana’s third-quarter results topped Wall Street’s expectations, but higher utilization rates and medical expenses led the company to lower its full-year profit guidance.

Humana lowered its full-year earnings forecast to $12.26 a share, down from its previous guidance of $13.77 a share. It reiterated its full-year adjusted-earnings outlook of $17 a share. - Jon ...

Bon Secours announced it has reached an agreement with Humana, allowing patients with Medicaid and Medicare Advantage plans ...

As more veterans enter retirement, Humana and USAA are collaborating to make healthcare simpler and more personal for those ...

Analysts are estimating that Humana will report an earnings per share (EPS) of $2.86. The announcement from Humana is eagerly anticipated, with investors seeking news of surpassing estimates and ...

Humana receives a "Hold" rating due to fair valuation and ongoing underperformance versus the S&P 500. HUM's Q3 earnings beat expectations, but a light FY 2025 outlook and higher medical loss ratio ...